Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis,Journal of Geriatric Psychiatry and Neurology

当前位置： X-MOL 学术 › J. Geriatr. Psychiatry Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis
Journal of Geriatric Psychiatry and Neurology ( IF 2.6 ) Pub Date : 2023-01-31 , DOI: 10.1177/08919887231154933
Ismaeel Yunusa ₁ , Nazia Rashid ₂ , Roxanna Seyedin ₃ , Deepika Paratane ₃ , Krithika Rajagopalan ₃

Affiliation

BackgroundThe current comparative efficacy, safety, and acceptability of atypical antipsychotics (AAPs) in treating Parkinson's Disease Psychosis (PDP) are not entirely understood.ObjectiveTo evalu...

中文翻译：